Moxalactam therapy for bacterial infections
- 1 November 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 141 (12) , 1607-1612
- https://doi.org/10.1001/archinte.141.12.1607
Abstract
Research from JAMA Internal Medicine — Moxalactam Therapy for Bacterial InfectionsThis publication has 9 references indexed in Scilit:
- Piperacillin therapy for serious bacterial infectionsThe American Journal of Medicine, 1980
- Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluidThe American Journal of Medicine, 1980
- Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolatesAntimicrobial Agents and Chemotherapy, 1980
- Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitisAntimicrobial Agents and Chemotherapy, 1980
- Pharmacology of a New 1-Oxa-β-lactam (LY127935) in Normal VolunteersAntimicrobial Agents and Chemotherapy, 1980
- Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infectionsArchives of internal medicine (1960), 1978
- Controlled Comparison of Amikacin and GentamicinNew England Journal of Medicine, 1977
- Ticarcillin for Treatment of Serious Infections with Gram-Negative BacteriaThe Journal of Infectious Diseases, 1976
- Carbenicillin: A Clinical and Laboratory EvaluationAnnals of Internal Medicine, 1970